Geburtshilfe Frauenheilkd 2014; 74(3): 250
DOI: 10.1055/s-0034-1368261
Comment
GebFra Science
Georg Thieme Verlag KG Stuttgart · New York

Response of the Uterus Commission of AGO to the Comment of M. Kolben, C. Dannecker and R. Kürzl

Kommentar der Kommission Uterus der AGO zur Stellungnahme von M. Kolben, C. Dannecker und R. Kürzl
G. Emons
1   Universitäts-Frauenklinik, Gynäkologisches Krebszentrum, Göttingen
,
P. Mallmann
2   Universitäts-Frauenklinik, Gynäkologisches Krebszentrum, Köln
,
acting for the Uterus Commission of AGO › Author Affiliations
Further Information

Publication History

Publication Date:
09 April 2014 (online)

We would like to thank our colleagues and the Munich Tumor Center for their comments. It is in the nature of things that statements such as those published in our update of the recommendations for the diagnosis and treatment of endometrial cancer are usually presented in an abridged form which cannot reflect all the nuances and the analysis. The basis for the carefully compiled statements will be explained in detail in the background texts of the upcoming S3 guideline for which funding has just been approved.

 
  • References

  • 1 Jacobs I, Gentry-Maharaj A, Burnell M et al. Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case control study with UK CTOCS cohort. Lancet Oncol 2011; 12: 38-48